Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures

14 September 2017

Vectorio® will be presented at the upcoming radiology congresses

Villepinte (France), September 14, 2017 (6:00 PM CEST) – Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, announced today that it has obtained the CE mark for its innovative conventional Trans-Arterial Chemo-Embolization (cTACE) mixing and injection system, Vectorio®.


We use cookies to improve your website experience and to gain insights into our websites’ users and traffic to make it even better. By continuing your navigation on our site without modifying the setting of your cookies, you accept the use of cookies. OKFind out more